Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones Nanotech Investing
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases Nanotech Investing
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT XR in the Journal of Clinical Endocrinology and Metabolism Nanotech Investing
Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process Nanotech Investing
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 Nanotech Investing
Longeveron, Selected as a StartUp Health Alzheimer's Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026 Nanotech Investing
